![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Kiadis Pharma raises fund for Phase II study of ATIR
Kiadis Pharma has raised EUR10m in a financing round to conduct Phase II study...
Pfizer Phase 3 fibromyalgia study of pregabalin meets primary endpoint
Pfizer Phase III study of pregabalin controlled-release (CR) formulation has met primary endpoint of...
Idera completes patient enrollment in Phase 2 trial of IMO-3100
Idera Pharmaceuticals has concluded enrolling patients in double-blind, placebo-controlled Phase 2 trial assessing IMO-3100...
Novavax pandemic influenza vaccine meets endpoints in two Phase 1 trials
Novavax A/H5N1 avian influenza vaccine candidate has met safety and immunogenicity endpoints in two...
Hybrigenics starts phase II clinical trial of inecalcitol in chronic lymphocytic leukemia
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus...
Millennium begins pharmacogenetics clinical outcomes study
Millennium Laboratories has commenced clinical outcomes study of its pharmacogenetic test. ...
PhaseBio initiates Phase 2b trial of Glymera
PhaseBio Pharmaceuticals has commenced patient dosing in a multicenter Phase 2b trial designed to...
Medistem announces initiation of critical limb ischemia study
Medistem and Shanghai Jia Fu Medical Apparatus have announced the initiation of critical limb...
ImmunoGen begins Phase I cancer trial of IMGN853
ImmunoGen has announced the commencement of the Phase I trial of IMGN853 in ovarian...
Dyax reports interim analysis data of Phase 2 ecallantide trial
Dyax has reported interim analysis results of Phase 2 trial of ecallantide for acute...